Thermo Fisher Scientific Inc (TMO) - 재무정보
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2021 | $39.21B | $10.22B | $19.46 | 132.1% | 31.43 |
| FY2022 | $44.91B | $8.51B | $17.63 | 120.1% | 31.61 |
| FY2023 | $42.86B | $7.32B | $15.45 | 110.8% | 34.59 |
| FY2024 | $42.88B | $7.72B | $16.53 | 95.9% | 32.10 |
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2021 | $39.21B | $10.22B | $19.46 | 132.1% | 31.43 |
| FY2022 | $44.91B | $8.51B | $17.63 | 120.1% | 31.61 |
| FY2023 | $42.86B | $7.32B | $15.45 | 110.8% | 34.59 |
| FY2024 | $42.88B | $7.72B | $16.53 | 95.9% | 32.10 |